Results 211 to 220 of about 1,864,273 (294)

Clean Energy and Health Expenditure in an African Setting: A Socioeconomic Analysis of Household Costs and Willingness to Pay. [PDF]

J Health Econ Outcomes Res
Adeloye D, Ogunleye WO, Ale BM, Akinnola OO, Iseolorunkanmi A, Akinyosoye AD, Okafor E, Olore AA, Sowunmi A, Niyi-Odumosu F, Ozoh OB, C2REST Nigeria Study.   +11 more
europepmc   +1 more source

Information and the Divergence Between Willingness-to-accept and Willingness-to-pay [PDF]

Charles D. Kolstad Rolando M. Guzman
core  

Cost‐utility analysis of nusinersen–risdiplam switch in patients with spinal muscular atrophy in Croatia: A discrete event simulation model

British Journal of Clinical Pharmacology, EarlyView.
Introduction In recent years, the treatment of spinal muscular atrophy (SMA), a rare disease, has significantly progressed, improving patients' survival and overall quality of life. However, current SMA treatments are expensive, and some (nusinersen) are very inconvenient for patients.
Andrej Belančić, Ivana Stević, Elvira Meni Maria Gkrinia, Dinko Vitezić, Slobodan Janković   +4 more
wiley   +1 more source

Herpes zoster vaccination among older adults in urban China: A mixed-methods study in Shenzhen. [PDF]

Hum Vaccin Immunother
Deng Z, Huang F, Lee ROL, Huang Y, Grépin KA.   +4 more
europepmc   +1 more source

Trust first, concerns second: An international vignette study of older adults' preferences towards deprescribing statins

British Journal of Clinical Pharmacology, EarlyView.
Abstract This study investigated the attitudes and beliefs of older adults towards deprescribing statins in Australia, the United Kingdom and the United States, using an online, vignette‐based study. Presented with a hypothetical scenario in which a general practitioner advised stopping simvastatin, participants rated their level of agreement and ...
Sarah E. Vordenberg, Noelia Dulo, Carissa Bonner, Eliza Ferguson, Vincent D. Marshall, Kristie Rebecca Weir   +5 more
wiley   +1 more source

What drives consumer participation in virtual CSR? The impact of external scenarios. [PDF]

PLoS One
Yang F, Song Y, Hu J, Zhang H.
europepmc   +1 more source

Efficacy, safety and cost‐effectiveness of CAR‐T therapy

British Journal of Clinical Pharmacology, EarlyView.
CAR T‐cells demonstrate high efficacy in blood cancers, including ALL, MM and DLBCL. Innovations target solid tumours despite challenges such as antigen escape. Combination therapies enhance the delivery and infiltration of CAR T cells. Toxicity, cost and resistance remain major barriers to clinical use.
Emina Karahmet Sher, Amina Džidić‐Krivić, Emma Pinjic, Nejra Selak, Kanita Omerbasic, Alexandar Chupin, Andrej Belancic, Almir Fajkic   +7 more
wiley   +1 more source

Comparing mental health professionals' willingness to use digital therapeutics: a cross-national survey in South Korea and Germany. [PDF]

BMC Health Serv Res
Moon DU, Park S, Kim MJ, Gutwinski S, Bermpohl F, Bajbouj M, Jeon HJ, Lütt A.   +7 more
europepmc   +1 more source

Do drugs approved via expedited approval pathways have therapeutic advantages? A systematic review and meta‐analysis

British Journal of Clinical Pharmacology, EarlyView.
Regulators use expedited approval pathways to speed market approval and patient access to promising new drugs. However, there is uncertainty about whether these pathways are successful in approving drugs with significant therapeutic advantages. This systematic review aims to examine the safety, effectiveness and cost‐effectiveness of drugs approved via
Ashleigh Hooimeyer, Eliza J. McEwin, Zhicheng Wang, Joel Lexchin, Barbara Mintzes   +4 more
wiley   +1 more source